Table 1 Patient distribution and hospitalization days, stratified by stage of disease and intraoral site
From: Oral cancer treatment costs in Greece and the effect of advanced disease
| Â | Stage 1 | Stage 2 | Stage 3 | Stage 4 | ||||
|---|---|---|---|---|---|---|---|---|
Location | No. of patients | Mean Hosp. Days (range) | No. of Patients | Mean Hosp. Days (range) | No. of Patients | Mean Hosp. Days (range) | No. of Patients | Mean Hosp. Days (range) |
Tongue | 5 | 11 (8–18) | 7 | 20,8 (8–68) | 7 | 15,8 (8–31) | 3 | 29 (14–41) |
Lip | 3 | 22 (10–30) | 8 | 18,3 (7–35) | 4 | 25,2 (15–43) | 0 | 0 |
Floor of Mouth | 1 | 17 | 11 | 18,2 (6–46) | 2 | 72 (58–86) | 3 | 33 (30–57) |
Alveolar Process | 1 | 10 | 5 | 26 (12–72) | 8 | 44 (10–122) | 5 | 49,5 (9–94) |
Bucal Mucosa | 0 | 0 | 4 | 21,5 (12–31) | 3 | 38,6 (24–56) | 0 | 0 |
Maxilla | 0 | 0 | 3 | 30,6 (23–32) | 0 | 0 | 0 | 0 |
Palate | 0 | 0 | 2 | 41,5 (13–70) | 2 | 51,5 (28–85) | 1 | 18 |
Retromolar Triangle | 0 | 0 | 1 | 13 | 5 | 32,4 (10–67) | 1 | 28 |